COVID-19 patients in the first wave showed higher maximum CRP (190.8 ± 133.3 vs. 99.1 ± 97.8 mg/L; p < 0.01), higher percentage of patients with pulmonary embolism (20 vs. 8%; p = 0.03)) in comparison to patients in the second wave. This evidence concerns the gene CRP and COVID-19.